BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30046391)

  • 1. Diagnostic tools in the differential diagnosis of giant cell-rich lesions of bone at biopsy.
    Rehkämper J; Steinestel K; Jeiler B; Elges S; Hekeler E; Huss S; Sperveslage J; Hardes J; Streitbürger A; Gosheger G; Wardelmann E; Baumhoer D; Trautmann M; Hartmann W
    Oncotarget; 2018 Jul; 9(53):30106-30114. PubMed ID: 30046391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy.
    Schaefer IM; Fletcher JA; Nielsen GP; Shih AR; Ferrone ML; Hornick JL; Qian X
    Cancer Cytopathol; 2018 Aug; 126(8):552-566. PubMed ID: 29757500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics.
    Presneau N; Baumhoer D; Behjati S; Pillay N; Tarpey P; Campbell PJ; Jundt G; Hamoudi R; Wedge DC; Loo PV; Hassan AB; Khatri B; Ye H; Tirabosco R; Amary MF; Flanagan AM
    J Pathol Clin Res; 2015 Apr; 1(2):113-23. PubMed ID: 27499898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma.
    Cleven AH; Höcker S; Briaire-de Bruijn I; Szuhai K; Cleton-Jansen AM; Bovée JV
    Am J Surg Pathol; 2015 Nov; 39(11):1576-83. PubMed ID: 26457357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of histone 3 mutations in osteoclast-rich bone tumors.
    Nohr E; Lee LH; Cates JM; Perizzolo M; Itani D
    Hum Pathol; 2017 Oct; 68():119-127. PubMed ID: 28882701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The identification of H3F3A mutation in giant cell tumour of the clivus and the histological diagnostic algorithm of other clival lesions permit the differential diagnosis in this location.
    Scotto di Carlo F; Divisato G; Iacoangeli M; Esposito T; Gianfrancesco F
    BMC Cancer; 2018 Apr; 18(1):358. PubMed ID: 29609578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors.
    Gong L; Bui MM; Zhang W; Sun X; Zhang M; Yi D
    Histol Histopathol; 2021 Jan; 36(1):61-68. PubMed ID: 33021329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H3.3 K36M Mutation as a Clinical Diagnosis Method of Suspected Chondroblastoma Cases.
    Mu H; Jiang Y; Xue L; Hua Y; Lin J; Cai Z
    Orthop Surg; 2021 Apr; 13(2):616-622. PubMed ID: 33620145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant.
    Lüke J; von Baer A; Schreiber J; Lübbehüsen C; Breining T; Mellert K; Marienfeld R; Schultheiss M; Möller P; Barth TFE
    Histopathology; 2017 Jul; 71(1):125-133. PubMed ID: 28211081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone.
    Yamamoto H; Iwasaki T; Yamada Y; Matsumoto Y; Otsuka H; Yoshimoto M; Kohashi K; Taguchi K; Yokoyama R; Nakashima Y; Oda Y
    Hum Pathol; 2018 Mar; 73():41-50. PubMed ID: 29241742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H3F3A-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three cases.
    Leinauer B; Wolf E; Werner M; Baumhoer D; Breining T; Luebke AM; Maas R; Schultheiß M; von Baer A; Sufi-Siavach A; Moritz C; Geißler S; Mellert K; Möller P; Barth TFE; Jundt G
    Histopathology; 2021 Nov; 79(5):720-730. PubMed ID: 33991114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anchored multiplex PCR for targeted next-generation sequencing reveals recurrent and novel USP6 fusions and upregulation of USP6 expression in aneurysmal bone cyst.
    Guseva NV; Jaber O; Tanas MR; Stence AA; Sompallae R; Schade J; Fillman AN; Miller BJ; Bossler AD; Ma D
    Genes Chromosomes Cancer; 2017 Apr; 56(4):266-277. PubMed ID: 27910166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [DNA sequencing of H3F3A mutations in H3.3 immunohistochemistry-negative giant cell tumors of bone].
    Gong LH; Zhang W; Sun XQ; Zhang M; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):190-193. PubMed ID: 33677880
    [No Abstract]   [Full Text] [Related]  

  • 14. [Giant-cell tumor of bone in 2022].
    Larousserie F; Audard V; Burns R; de Pinieux G
    Ann Pathol; 2022 Apr; 42(3):214-226. PubMed ID: 35523609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone.
    Righi A; Mancini I; Gambarotti M; Picci P; Gamberi G; Marraccini C; Dei Tos AP; Simi L; Pinzani P; Franchi A
    Hum Pathol; 2017 Oct; 68():128-135. PubMed ID: 28899740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of H3.3 G34W mutant-specific antibody in giant cell tumors of bone and its diagnostic value].
    Wang X; Wu N; Zhang RS; Wei X; Ji RH; Ma HH; Zhou XJ; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2020 Feb; 49(2):116-121. PubMed ID: 32074722
    [No Abstract]   [Full Text] [Related]  

  • 17. Absence of H3F3A mutation in a subset of malignant giant cell tumor of bone.
    Yoshida KI; Nakano Y; Honda-Kitahara M; Wakai S; Motoi T; Ogura K; Sano N; Shibata T; Okuma T; Iwata S; Kawai A; Ichimura K; Yoshida A
    Mod Pathol; 2019 Dec; 32(12):1751-1761. PubMed ID: 31285528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chondroblastoma of the patella with secondary aneurysmal bone cyst, an easily misdiagnosed bone tumor:a case report with literature review.
    Zheng J; Niu N; Shi J; Zhang X; Zhu X; Wang J; Liu C
    BMC Musculoskelet Disord; 2021 Apr; 22(1):381. PubMed ID: 33892701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of H3F3A p.G35W and p.G35R in giant cell tumor of bone by Allele Specific Locked Nucleic Acid quantitative PCR (ASLNAqPCR).
    Gamberi G; Morandi L; Benini S; Resca A; Cocchi S; Magagnoli G; Donati DM; Righi A; Gambarotti M
    Pathol Res Pract; 2018 Jan; 214(1):89-94. PubMed ID: 29254795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of Fluorescence
    Li L; Bui MM; Zhang M; Sun X; Han G; Zhang T; Huang X; Ding Y
    Ann Clin Lab Sci; 2019 Sep; 49(5):590-597. PubMed ID: 31611201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.